clinical trial glp 1 GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness New oral GLP-1 drug delivers
Description
MRI-based studies from the SURPASS-3 program and related tirzepatide trials show that tirzepatide produces large reductions in visceral and liver fat while preserving a higher percentage of lean muscle
The point is this: even if both semaglutide and tirzepatide fail, the medication pipeline contains multiple next-generation options targeting different receptor combinations
Cooks distance was evaluated for each data point to ensure no point was overly influential in the fitted model
Semaglutide starts at ~$249/month on a standard plan, dropping to ~$199/month with a 3-month supply
[ii] Drucker DJ
